Catalyst
Slingshot members are tracking this event:
Opko (OPK) commences Phase 3 trial for hGH-CTP in pediatric patients; company preparing for BLA submisison
Do you think this event is important to the companies below? How will it affect their stock price?
| Related Companies | Importance
|
Impact on Stocks
|
||||
|---|---|---|---|---|---|---|
| OPK |
|
|
||||
Additional Information
Slingshot Insights Explained
Catalyst Date
Occurred on:
Aug 29, 2019
Occurred Source:
https://www.opko.com/news-media/press-releases/detail/366/opko-completes-pivotal-phase-3-study-for-somatrogon
Related Projects
-
Don’t see a project related to the catalyst you care about?
Related Keywords
Phase 3 Study, Hgh-ctp, Bla Submission
